...John K. Leypoldt; Jorge Echeverri; Kai Harenski; Kuljinder Singh Introduction: Hypophosphatemia is common during continuous renal replacement therapy (CRRT), but serum phosphate levels can potentially be maintained during treatment by either intravenous phosphate supplementation or addition...

... with erythropoiesis-stimulating agents, 22 received once-weekly intravenous iron and 17 received daily oral iron with iron-containing phosphate binders. Intact FGF23 and biomarkers of iron metabolism were measured from blood samples drawn before each HD session, at baseline and on days 3, 5, 7, and 14. Results...

... phosphate (Pi) and vascular calcification score (VCS). Methods: Vascular smooth muscle cells (VSMCs) were cultured with 3.5 mM Na 3 PO 4 (Pi) with 10% uremic serum and calcium deposition, markers of osteoblastic transformation, and apoptosis were evaluated. Results: Culture with uremic serum and high-Pi...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. HD Mortality Calcium Phosphate Parathyroid hormone Mineral and bone disorders are common occurrences in chronic...

...% tidal with initial fill volume (FV) 2 liters, (B) 50% tidal with 2.2 liters initial FV, (C) 2.2 liters initial FV with 70% tidal, (D) as in B, with one complete renewal of the initial FV at midsession, (E) 2.2 liters FV with breakpoint modality. Urea, creatinine and phosphate peritoneal clearances...

...Jan Poleszczuk; Malgorzata Debowska; Alicja Wojcik-Zaluska; Andrzej Ksiazek; Wojciech Zaluska Background/Aims: Various body-regulating mechanisms try to counteract rapid changes in serum phosphate levels during hemodialysis (HD). Neither recently proposed nor other existing standard compartment...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2015 Chronic kidney disease Dialysis Haemodiafiltration High-flux dialysis Anaemia Phosphate Cardiovascular...

... the cost effectiveness of phosphate binders in preventing CV mortality and morbidity over 7 years was performed. Methods: Morbid or fatal events occurring in 750 chronic HD patients were recorded. Statistical analysis evaluated the distribution of variables and the effect of sevelamer on survival. A cost...

...Carmine Zoccali; Mahmut Ilker Yilmaz; Francesca Mallamaci High FGF23 predicts renal function loss in chronic kidney disease (CKD) patients and graft failure in transplant patients. FGF23, parathyroid hormone and serum phosphate are all interrelated but among these CKD-MBD biomarkers only FGF23...

... and in two 2-hour treatments on consecutive days (Polyflux 2.1 m 2 , QB 451 ± 53 ml/min, QD 598 ± 13 ml/min). Blood urea, creatinine, phosphate, β 2 -microglobulin, complement factor D and advanced glycation end products were analyzed before, during and after HDF for 24-48 h. Results: Applying two 2-hour HDF...

...Leonard M. Ebah; Mehvosh Akhtar; Ian Wilde; Graeme Hookway; Mark Vincent; Christopher Reeves; John Denton; John Woods; Sandip Mitra Background/Aims: Intensive haemodialysis (HD) sometimes causes hypophosphataemia, but phosphate-containing dialysate is not readily available. We examined...

...Eberhard Ritz; Marie-Luise Gross The recent recognition that hyperphosphatemia is a strong predictor of survival on dialysis has rekindled interest in the regulation and control of serum phosphate. In incipient renal failure hyperphosphatemia is prevented by increased fractional renal phosphate...

...Ranistha Ratanarat; Alessandra Brendolan; Gopel Volker; Monica Bonello; Gabriella Salvatori; Emilio Andrikos; Asuman Yavuz; Carlo Crepaldi; Claudio Ronco Background: An abnormal serum phosphate concentration is common in acute renal failure patients, with a reported incidence of 65–80%. Phosphate...

... affecting calcium and phosphate control are not modifiable; however, we wished to determine whether differences in dialysis treatment could affect achievement of KDOQI clinical guideline targets. Methods: We audited pre-mid-week session calcium and phosphate levels in 5,324 adult patients receiving thrice...

...Markus Ketteler; Patrick H. Biggar Data on calcium and phosphate metabolism in the predialysis stages of chronic kidney disease (CKD) are scarce when compared with the available information on patients on dialysis. Visible derangements of calcium and phosphate levels start to become apparent when...

... in the pathophysiology of SHPT, between them the emerging role of the PT vitamin D receptor and calcium-sensing receptor. Furthermore, recent studies indicate that the fibroblast growth factor-23 may play a central role in the regulation of phosphate-vitamin D metabolism in CKD. Certainly, in the next future, these new...

...Piergiorgio Messa; Roberta Cerutti; Brigida Brezzi; Carlo Alfieri; Mario Cozzolino Calcium and phosphate changes, besides their involvement in bone disease, have been claimed to also be involved in the increased vascular morbidity and mortality of dialysis patients. Even after the recent advances...

... of chronic kidney disease (CKD) does the relationship between elevated phosphate levels, vascular calcification and increased cardiovascular mortality begin? Therefore, the purpose of the current study was to critically review the current literature regarding this issue. Methods: We performed a systematic...

... to oHDF, whereas patients in group B began with oHDF and were treated with HD afterwards. Intradialytic morbid events (IME), such as symptomatic hypotension or muscle cramps, were noted in case of appearance. Blood parameters reflecting anaemic status, phosphate status, lipid metabolism, oxidative stress...

... optimize these parameters of iP mass balance and reduce phosphate accumulation in tissues. 22 1 2003 © 2003 S. Karger AG, Basel 2003 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced...